© Rosalind Scientific LLC 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > LMB763 (nidufexor)
<< Back to February
selective FXR partial agonist
orally efficacious in NASH models
from two 3M compound HTS and LBD
J. Med. Chem., Jan. 15, 2020
Novartis (GNF), San Diego, CA
LMB763 (nidufexor) (Novartis (GNF) oral in vivo selective FXR partial agonist)
Unlock this content with a Premium membership to read it now.